These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 11364324

  • 1. FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration.
    AIDS Treat News; 1997 May 01; (No 270):3. PubMed ID: 11364324
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiretroviral therapy in HIV/AIDS: update from San Francisco.
    Laurence J.
    AIDS Read; 2000 Mar 01; 10(3):133-4. PubMed ID: 10758008
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr 01; (no 10):18. PubMed ID: 11362343
    [Abstract] [Full Text] [Related]

  • 6. FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James.
    Feigal D.
    AIDS Treat News; 1997 Jun 20; (No 273):1-5. PubMed ID: 11364399
    [Abstract] [Full Text] [Related]

  • 7. AIDS researchers seek criteria for vaccines.
    Check E.
    Nature; 2003 May 08; 423(6936):107. PubMed ID: 12736647
    [No Abstract] [Full Text] [Related]

  • 8. Let there be drugs.
    Gilden D.
    GMHC Treat Issues; 1996 Feb 08; 10(2):1, 13-6. PubMed ID: 11363380
    [Abstract] [Full Text] [Related]

  • 9. On approval.
    Huff B.
    GMHC Treat Issues; 2001 Oct 08; 15(10):5-8. PubMed ID: 11727570
    [No Abstract] [Full Text] [Related]

  • 10. FDA workshop on clinical trial design, September 6-7--registration by Aug. 18. Food and Drug Administration.
    James JS.
    AIDS Treat News; 1995 Aug 04; (no 228):5-6. PubMed ID: 11362627
    [Abstract] [Full Text] [Related]

  • 11. Symptom-reduction trials at FDA clinical trials workshop. Food and Drug Administration.
    James JS.
    AIDS Treat News; 1995 Sep 29; (no 231):7. PubMed ID: 11362873
    [Abstract] [Full Text] [Related]

  • 12. Experimental drug quickly suppresses HIV.
    AIDS Read; 2005 Apr 29; 15(4):150. PubMed ID: 15844233
    [No Abstract] [Full Text] [Related]

  • 13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K.
    Verh K Acad Geneeskd Belg; 2001 Apr 29; 63(5):447-73. PubMed ID: 11813503
    [Abstract] [Full Text] [Related]

  • 14. FDA notifications. NRTI Emtriva receives FDA approval.
    AIDS Alert; 2003 Oct 29; 18(10):131-2. PubMed ID: 14686301
    [Abstract] [Full Text] [Related]

  • 15. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
    James JS.
    AIDS Treat News; 1995 Apr 07; (no 220):4-5. PubMed ID: 11362320
    [Abstract] [Full Text] [Related]

  • 16. FDA clarifies rules, allows combining antiretrovirals in clinical trials. Food and Drug Administration.
    AIDS Treat News; 1999 Nov 19; (No 331):5-6. PubMed ID: 11367127
    [Abstract] [Full Text] [Related]

  • 17. FDA notifications. New antiretroviral guidelines issued.
    AIDS Alert; 2005 Jan 19; 20(1):11-2. PubMed ID: 15717358
    [No Abstract] [Full Text] [Related]

  • 18. AIDS task force grapples with faster access to protease drugs.
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1995 Mar 19; 1(2):6-11. PubMed ID: 11362314
    [Abstract] [Full Text] [Related]

  • 19. Opinion paper. Resistance to new anti-HIV agents: problems in the pathway of drug registration.
    Dalmau D, Klimkait T, Telenti A.
    Antivir Ther; 2005 Mar 19; 10(7):867-72. PubMed ID: 16312184
    [Abstract] [Full Text] [Related]

  • 20. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
    AIDS Alert; 2006 Jan 19; 21(1):11-2. PubMed ID: 16470945
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.